KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Share-based Compensation (2016 - 2025)

Idexx Laboratories (IDXX) has 17 years of Share-based Compensation data on record, last reported at $16.1 million in Q4 2025.

  • For Q4 2025, Share-based Compensation rose 13.0% year-over-year to $16.1 million; the TTM value through Dec 2025 reached $60.0 million, changed 0.47%, while the annual FY2025 figure was $60.0 million, 0.47% changed from the prior year.
  • Share-based Compensation reached $16.1 million in Q4 2025 per IDXX's latest filing, up from $14.4 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $16.1 million in Q4 2025 and bottomed at $8.9 million in Q1 2021.
  • Average Share-based Compensation over 5 years is $13.4 million, with a median of $14.3 million recorded in 2024.
  • Peak YoY movement for Share-based Compensation: skyrocketed 36.71% in 2022, then dropped 9.33% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $9.7 million in 2021, then surged by 36.71% to $13.3 million in 2022, then increased by 14.64% to $15.2 million in 2023, then fell by 6.34% to $14.3 million in 2024, then rose by 13.0% to $16.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Share-based Compensation were $16.1 million in Q4 2025, $14.4 million in Q3 2025, and $14.9 million in Q2 2025.